Advertisement
Screener

DAMORA THERAPEUTICS, INC. (DMRA) Forms 3, 4 and 5: Stock Options

1.4 / 5 stars · 6/22 Roast Me

Add as a preferred source on Google

DAMORA THERAPEUTICS, INC. Forms 3, 4 and 5: Stock Options

Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 94 rows, 94 shown. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.

  • 2026-08-12: Reporting owner Cheng Andrew; Form 4; Security Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
  • 2026-05-08: Reporting owner Burkavage Brian; Form 3; Security Stock Option (right to buy); Transaction Holding.
  • 2026-03-30: Reporting owner Jarrett Jennifer; Form 4; Security Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
  • 2026-03-23: Reporting owner Winslow Garrett; Form 4; Security Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).

DMRA insiders transactions against the stock price

Blue: Split-adjusted close · Orange: Cumulative dividend-reinvested close

$4.70$7.06$10.60$15.91$23.88$35.852025-11-062026-11-06$2.11$4.51$9.63$20.58$43.98$93.982021-11-082026-11-06$2.11$6.14$17.89$52.11$151.77$442.052020-10-292026-11-06$2.11$6.14$17.89$52.11$151.77$442.052020-10-292026-11-06$2.11$6.14$17.89$52.11$151.77$442.052020-10-292026-11-062020-11-19: 2 award or grants at $399.50 close — Dallas Jayson Donald Alexander2021-01-05: 4 award or grants at $323.13 close — Schambye Hans T., Pedersen Anders, Freve Jonathan and 1 more2021-01-08: 2 award or grants at $325.00 close — Prener Anne2021-05-26: 4 award or grants at $121.75 close — Dallas Jayson Donald Alexander, Prener Anne, Khuong Chau Quang and 1 more2021-06-15: 1 award or grant at $131.13 close — Winslow Garrett2021-11-17: 2 award or grants at $76.25 close — Khuong Chau Quang, GOLDFISCHER CARL2022-01-04: 5 award or grants at $82.75 close — Schambye Hans T., Lindmark Bertil, Pedersen Anders and 2 more2022-02-15: 1 award or grant at $52.75 close — Oestreich Stephanie2022-06-14: 5 award or grants at $45.25 close — Munshi Amit, Shapiro David, Prener Anne and 2 more2023-01-04: 6 award or grants at $36.25 close — Schambye Hans T., Oestreich Stephanie, Pedersen Anders and 3 more2023-06-14: 5 award or grants at $54.50 close — Shapiro David, Prener Anne, Munshi Amit and 2 more2023-06-17: 1 award or grant at $71.00 close — Dallas Jayson Donald Alexander2024-06-20: 5 award or grants at $12.28 close — Prener Anne, Munshi Amit, GOLDFISCHER CARL and 2 more2024-10-09: 4 award or grants at $7.16 close — Kronmiller Matthew, Firmani Lori, Winslow Garrett and 1 more2024-10-11: 2 award or grants at $7.27 close — WECHSLER AMY B2025-01-03: 4 award or grants at $5.70 close — Winslow Garrett, Firmani Lori, Kronmiller Matthew and 1 more2025-06-18: 6 award or grants at $3.33 close — Dallas Jayson Donald Alexander, Munshi Amit, Shapiro David and 3 more2026-01-05: 2 award or grants at $21.26 close — Sattarzadeh Sherwin, Hewes L. Becker2026-03-23: 6 award or grants at $23.05 close — Winslow Garrett, Turtle Cameron, Landsittel Michael and 3 more2026-03-30: 1 award or grant at $24.27 close — Jarrett Jennifer2026-08-12: 1 award or grant at $31.00 close — Cheng Andrew

Logarithmic scale. Both lines share the same starting value for the selected range.

Markers: each transaction type positioned at that session's split-adjusted close. Tooltips retain the reported transaction price when available.

Transaction dateReporting ownerFormSecurityTransactionSharesPricePrice that dayFiling
2026-08-12Cheng Andrew
Director		4Stock Option (right to buy)
Derivative · Direct		A Grant, award or other acquisition pursuant to Rule 16b-3(d)+30,350
30,350 owned after		$31.00
exercise price		$31.002026-08-13
2026-05-08
holding as of filing		Burkavage Brian
Officer (SVP, Finance)		3Stock Option (right to buy)
Derivative · Direct		Holding$32.00
exercise price		2026-05-08
2026-03-30Jarrett Jennifer
Director, Officer (See Remarks)		4Stock Option (right to buy)
Derivative · Direct		A Grant, award or other acquisition pursuant to Rule 16b-3(d)+1,500,000
1,500,000 owned after		$25.50
exercise price		$24.272026-04-01
2026-03-23Winslow Garrett
Officer (General Counsel)		4Stock Option (right to buy)
Derivative · Direct		A Grant, award or other acquisition pursuant to Rule 16b-3(d)+250,000
250,000 owned after		$23.05
exercise price		$23.052026-03-25
2026-03-23Turtle Cameron
Director		4Stock Option (right to buy)
Derivative · Direct		A Grant, award or other acquisition pursuant to Rule 16b-3(d)+37,313
37,313 owned after		$23.05
exercise price		$23.052026-03-25
2026-03-23Landsittel Michael
Director		4Stock Option (right to buy)
Derivative · Direct		A Grant, award or other acquisition pursuant to Rule 16b-3(d)+37,313
37,313 owned after		$23.05
exercise price		$23.052026-03-25
2026-03-23Fairmount Healthcare Fund II L.P. | Harwin Peter Evan | Kiselak Tomas | Fairmount Healthcare Co-Invest V L.P. | Fairmount Funds Management LLC
Director, 10% Owner | Director, 10% Owner | 10% Owner | Director, 10% Owner | Director, 10% Owner		4Stock Option (right to buy)
Derivative · Indirect · By: Peter Harwin		A Grant, award or other acquisition pursuant to Rule 16b-3(d)+37,313
37,313 owned after		$23.05
exercise price		$23.052026-03-25
2026-03-23CAIN CHRISTOPHER W.
Director		4Stock Option (right to buy)
Derivative · Direct		A Grant, award or other acquisition pursuant to Rule 16b-3(d)+37,313
37,313 owned after		$23.05
exercise price		$23.052026-03-25
2026-03-23Bruno Julianne
Director		4Stock Option (right to buy)
Derivative · Direct		A Grant, award or other acquisition pursuant to Rule 16b-3(d)+37,313
37,313 owned after		$23.05
exercise price		$23.052026-03-25
2026-01-05Sattarzadeh Sherwin
Officer (Chief Operating Officer)		4Stock Option (right to buy)
Derivative · Direct		A Grant, award or other acquisition pursuant to Rule 16b-3(d)+444,209
444,209 owned after		$21.82
exercise price		$21.262026-01-26
2026-01-05Hewes L. Becker
Officer (Chief Medical Officer)		4Stock Option (right to buy)
Derivative · Direct		A Grant, award or other acquisition pursuant to Rule 16b-3(d)+528,603
528,603 owned after		$21.82
exercise price		$21.262026-01-07
2025-06-18Dallas Jayson Donald Alexander
Director		4Stock Option (right to buy)
Derivative · Direct		A Grant, award or other acquisition pursuant to Rule 16b-3(d)+720
720 owned after		$3.22
exercise price		$3.332025-06-20
2025-06-18Munshi Amit
Director		4Stock Option (right to buy)
Derivative · Direct		A Grant, award or other acquisition pursuant to Rule 16b-3(d)+720
720 owned after		$3.22
exercise price		$3.332025-06-20
2025-06-18Shapiro David
Director		4Stock Option (right to buy)
Derivative · Direct		A Grant, award or other acquisition pursuant to Rule 16b-3(d)+720
720 owned after		$3.22
exercise price		$3.332025-06-20
2025-06-18Prener Anne
Director		4Stock Option (right to buy)
Derivative · Direct		A Grant, award or other acquisition pursuant to Rule 16b-3(d)+720
720 owned after		$3.22
exercise price		$3.332025-06-20
2025-06-18WECHSLER AMY B
Director		4Stock Option (right to buy)
Derivative · Direct		A Grant, award or other acquisition pursuant to Rule 16b-3(d)+720
720 owned after		$3.22
exercise price		$3.332025-06-20
2025-06-18GOLDFISCHER CARL
Director		4Stock Option (right to buy)
Derivative · Direct		A Grant, award or other acquisition pursuant to Rule 16b-3(d)+1,440
1,440 owned after		$3.22
exercise price		$3.332025-06-20
2025-01-03Winslow Garrett
Officer (General Counsel)		4Stock Option (right to buy)
Derivative · Direct		A Grant, award or other acquisition pursuant to Rule 16b-3(d)+6,000
6,000 owned after		$5.70
exercise price		$5.702025-01-07
2025-01-03Firmani Lori
Officer (Interim CFO)		4Stock Option (right to buy)
Derivative · Direct		A Grant, award or other acquisition pursuant to Rule 16b-3(d)+5,000
5,000 owned after		$5.70
exercise price		$5.702025-01-07
2025-01-03Kronmiller Matthew
Officer (EVP Strategy and CBO)		4Stock Option (right to buy)
Derivative · Direct		A Grant, award or other acquisition pursuant to Rule 16b-3(d)+6,000
6,000 owned after		$5.70
exercise price		$5.702025-01-07
2025-01-03Schambye Hans T.
Director, Officer (Chief Executive Officer)		4Stock Option (right to buy)
Derivative · Direct		A Grant, award or other acquisition pursuant to Rule 16b-3(d)+16,400
16,400 owned after		$5.70
exercise price		$5.702025-01-07
2024-10-11WECHSLER AMY B
Director		4Stock Option (right to buy)
Derivative · Direct		A Grant, award or other acquisition pursuant to Rule 16b-3(d)+720
720 owned after		$6.92
exercise price		$7.272024-10-15
2024-10-11WECHSLER AMY B
Director		4Stock Option (right to buy)
Derivative · Direct		A Grant, award or other acquisition pursuant to Rule 16b-3(d)+480
480 owned after		$6.92
exercise price		$7.272024-10-15
2024-10-09Kronmiller Matthew
Officer (EVP Strategy and CBO)		4Stock Option (right to buy)
Derivative · Direct		A Grant, award or other acquisition pursuant to Rule 16b-3(d)+8,600
8,600 owned after		$7.49
exercise price		$7.162024-10-11
2024-10-09Firmani Lori
Officer (Interim CFO)		4Stock Option (right to buy)
Derivative · Direct		A Grant, award or other acquisition pursuant to Rule 16b-3(d)+13,000
13,000 owned after		$7.49
exercise price		$7.162024-10-11
2024-10-09Winslow Garrett
Officer (General Counsel)		4Stock Option (right to buy)
Derivative · Direct		A Grant, award or other acquisition pursuant to Rule 16b-3(d)+15,600
15,600 owned after		$7.49
exercise price		$7.162024-10-11
2024-10-09Schambye Hans T.
Director, Officer (Chief Executive Officer)		4Stock Option (right to buy)
Derivative · Direct		A Grant, award or other acquisition pursuant to Rule 16b-3(d)+44,100
44,100 owned after		$7.49
exercise price		$7.162024-10-11
2024-08-16
holding as of filing		Firmani Lori
Officer (Interim CFO)		3Stock Option (right to buy)
Derivative · Direct		Holding$13.00
exercise price		2024-08-16
2024-08-16
holding as of filing		Firmani Lori
Officer (Interim CFO)		3Stock Option (right to buy)
Derivative · Direct		Holding$3.24
exercise price		2024-08-16
2024-08-16
holding as of filing		Firmani Lori
Officer (Interim CFO)		3Stock Option (right to buy)
Derivative · Direct		Holding$1.21
exercise price		2024-08-16
2024-06-20Prener Anne
Director		4Stock Option (right to buy)
Derivative · Direct		A Grant, award or other acquisition pursuant to Rule 16b-3(d)+18,000
18,000 owned after		$0.49
exercise price		$12.282024-06-21
2024-06-20Munshi Amit
Director		4Stock Option (right to buy)
Derivative · Direct		A Grant, award or other acquisition pursuant to Rule 16b-3(d)+18,000
18,000 owned after		$0.49
exercise price		$12.282024-06-21
2024-06-20GOLDFISCHER CARL
Director		4Stock Option (right to buy)
Derivative · Direct		A Grant, award or other acquisition pursuant to Rule 16b-3(d)+36,000
36,000 owned after		$0.49
exercise price		$12.282024-06-21
2024-06-20Shapiro David
Director		4Stock Option (right to buy)
Derivative · Direct		A Grant, award or other acquisition pursuant to Rule 16b-3(d)+18,000
18,000 owned after		$0.49
exercise price		$12.282024-06-21
2024-06-20Dallas Jayson Donald Alexander
Director		4Stock Option (right to buy)
Derivative · Direct		A Grant, award or other acquisition pursuant to Rule 16b-3(d)+18,000
18,000 owned after		$0.49
exercise price		$12.282024-06-21
2023-06-17Dallas Jayson Donald Alexander
Director		4Stock Option (right to buy)
Derivative · Direct		A Grant, award or other acquisition pursuant to Rule 16b-3(d)+18,000
18,000 owned after		$2.12
exercise price		$71.002023-06-15
2023-06-14Shapiro David
Director		4Stock Option (right to buy)
Derivative · Direct		A Grant, award or other acquisition pursuant to Rule 16b-3(d)+18,000
18,000 owned after		$2.12
exercise price		$54.502023-06-15
2023-06-14Prener Anne
Director		4Stock Option (right to buy)
Derivative · Direct		A Grant, award or other acquisition pursuant to Rule 16b-3(d)+18,000
18,000 owned after		$2.12
exercise price		$54.502023-06-15
2023-06-14Munshi Amit
Director		4Stock Option (right to buy)
Derivative · Direct		A Grant, award or other acquisition pursuant to Rule 16b-3(d)+18,000
18,000 owned after		$2.12
exercise price		$54.502023-06-15
2023-06-14GOLDFISCHER CARL
Director		4Stock Option (right to buy)
Derivative · Direct		A Grant, award or other acquisition pursuant to Rule 16b-3(d)+36,000
36,000 owned after		$2.12
exercise price		$54.502023-06-15
2023-06-14Khuong Chau Quang
Director		4Stock Option (right to buy)
Derivative · Direct		A Grant, award or other acquisition pursuant to Rule 16b-3(d)+18,000
18,000 owned after		$2.12
exercise price		$54.502023-06-15
2023-01-04Schambye Hans T.
Director, Officer (Chief Executive Officer)		4Stock Option (right to buy)
Derivative · Direct		A Grant, award or other acquisition pursuant to Rule 16b-3(d)+300,000
300,000 owned after		$1.21
exercise price		$36.252023-01-05
2023-01-04Oestreich Stephanie
Officer (Chief Business Officer)		4Stock Option (right to buy)
Derivative · Direct		A Grant, award or other acquisition pursuant to Rule 16b-3(d)+80,000
80,000 owned after		$1.21
exercise price		$36.252023-01-05
2023-01-04Pedersen Anders
Officer (Chief Operating Officer)		4Stock Option (right to buy)
Derivative · Direct		A Grant, award or other acquisition pursuant to Rule 16b-3(d)+115,000
115,000 owned after		$1.21
exercise price		$36.252023-01-05
2023-01-04Freve Jonathan
Officer (Chief Financial Officer)		4Stock Option (right to buy)
Derivative · Direct		A Grant, award or other acquisition pursuant to Rule 16b-3(d)+115,000
115,000 owned after		$1.21
exercise price		$36.252023-01-05
2023-01-04Winslow Garrett
Officer (General Counsel)		4Stock Option (right to buy)
Derivative · Direct		A Grant, award or other acquisition pursuant to Rule 16b-3(d)+80,000
80,000 owned after		$1.21
exercise price		$36.252023-01-05
2023-01-04Lindmark Bertil
Officer (Chief Medical Officer)		4Stock Option (right to buy)
Derivative · Direct		A Grant, award or other acquisition pursuant to Rule 16b-3(d)+115,000
115,000 owned after		$1.21
exercise price		$36.252023-01-05
2022-06-14Munshi Amit
Director		4Stock Option (right to buy)
Derivative · Direct		A Grant, award or other acquisition pursuant to Rule 16b-3(d)+18,000
18,000 owned after		$1.98
exercise price		$45.252022-06-15
2022-06-14Shapiro David
Director		4Stock Option (right to buy)
Derivative · Direct		A Grant, award or other acquisition pursuant to Rule 16b-3(d)+18,000
18,000 owned after		$1.98
exercise price		$45.252022-06-15
2022-06-14Prener Anne
Director		4Stock Option (right to buy)
Derivative · Direct		A Grant, award or other acquisition pursuant to Rule 16b-3(d)+18,000
18,000 owned after		$1.98
exercise price		$45.252022-06-15
2022-06-14GOLDFISCHER CARL
Director		4Stock Option (right to buy)
Derivative · Direct		A Grant, award or other acquisition pursuant to Rule 16b-3(d)+36,000
36,000 owned after		$1.98
exercise price		$45.252022-06-15
2022-06-14Dallas Jayson Donald Alexander
Director		4Stock Option (right to buy)
Derivative · Direct		A Grant, award or other acquisition pursuant to Rule 16b-3(d)+18,000
18,000 owned after		$1.98
exercise price		$45.252022-06-15
2022-02-15Oestreich Stephanie
Officer (Chief Business Officer)		4Stock Option (right to buy)
Derivative · Direct		A Grant, award or other acquisition pursuant to Rule 16b-3(d)+140,000
140,000 owned after		$2.07
exercise price		$52.752022-02-15
2022-01-04Schambye Hans T.
Director, Officer (Chief Executive Officer)		4Stock Option (right to buy)
Derivative · Direct		A Grant, award or other acquisition pursuant to Rule 16b-3(d)+287,500
287,500 owned after		$3.24
exercise price		$82.752022-01-06
2022-01-04Lindmark Bertil
Officer (Chief Medical Officer)		4Stock Option (right to buy)
Derivative · Direct		A Grant, award or other acquisition pursuant to Rule 16b-3(d)+118,750
118,750 owned after		$3.24
exercise price		$82.752022-01-06
2022-01-04Pedersen Anders
Officer (Chief Operating Officer)		4Stock Option (right to buy)
Derivative · Direct		A Grant, award or other acquisition pursuant to Rule 16b-3(d)+118,750
118,750 owned after		$3.24
exercise price		$82.752022-01-06
2022-01-04Winslow Garrett
Officer (General Counsel)		4Stock Option (right to buy)
Derivative · Direct		A Grant, award or other acquisition pursuant to Rule 16b-3(d)+75,000
75,000 owned after		$3.24
exercise price		$82.752022-01-06
2022-01-04Freve Jonathan
Officer (Chief Financial Officer)		4Stock Option (right to buy)
Derivative · Direct		A Grant, award or other acquisition pursuant to Rule 16b-3(d)+118,750
118,750 owned after		$3.24
exercise price		$82.752022-01-06
2021-11-17Khuong Chau Quang
Director		4Stock Option (right to buy)
Derivative · Direct		A Grant, award or other acquisition pursuant to Rule 16b-3(d)+9,000
9,000 owned after		$3.23
exercise price		$76.252021-11-19
2021-11-17GOLDFISCHER CARL
Director		4Stock Option (right to buy)
Derivative · Direct		A Grant, award or other acquisition pursuant to Rule 16b-3(d)+18,000
18,000 owned after		$3.23
exercise price		$76.252021-11-19
2021-06-15Winslow Garrett
Officer (General Counsel)		4Stock Option (right to buy)
Derivative · Direct		A Grant, award or other acquisition pursuant to Rule 16b-3(d)+120,000
120,000 owned after		$5.61
exercise price		$131.132021-06-16
2021-05-26Dallas Jayson Donald Alexander
Director		4Stock Option (right to buy)
Derivative · Direct		A Grant, award or other acquisition pursuant to Rule 16b-3(d)+18,000
18,000 owned after		$4.93
exercise price		$121.752021-05-28
2021-05-26Prener Anne
Director		4Stock Option (right to buy)
Derivative · Direct		A Grant, award or other acquisition pursuant to Rule 16b-3(d)+18,000
18,000 owned after		$4.93
exercise price		$121.752021-05-28
2021-05-26Khuong Chau Quang
Director		4Stock Option (right to buy)
Derivative · Direct		A Grant, award or other acquisition pursuant to Rule 16b-3(d)+18,000
18,000 owned after		$4.93
exercise price		$121.752021-05-28
2021-05-26GOLDFISCHER CARL
Director		4Stock Option (right to buy)
Derivative · Direct		A Grant, award or other acquisition pursuant to Rule 16b-3(d)+18,000
18,000 owned after		$4.93
exercise price		$121.752021-05-28
2021-01-08Prener Anne
Director		4Stock Option (right to buy)
Derivative · Direct		A Grant, award or other acquisition pursuant to Rule 16b-3(d)+18,000
18,000 owned after		$13.12
exercise price		$325.002021-01-08
2021-01-08Prener Anne
Director		4Stock Option (right to buy)
Derivative · Direct		A Grant, award or other acquisition pursuant to Rule 16b-3(d)+6,000
6,000 owned after		$13.12
exercise price		$325.002021-01-08
2021-01-05Schambye Hans T.
Director, Officer (Chief Executive Officer)		4Stock Option (right to buy)
Derivative · Direct		A Grant, award or other acquisition pursuant to Rule 16b-3(d)+230,000
230,000 owned after		$13.00
exercise price		$323.132021-01-07
2021-01-05Pedersen Anders
Officer (Chief Operating Officer)		4Stock Option (right to buy)
Derivative · Direct		A Grant, award or other acquisition pursuant to Rule 16b-3(d)+100,000
100,000 owned after		$13.00
exercise price		$323.132021-01-07
2021-01-05Freve Jonathan
Officer (Chief Financial Officer)		4Stock Option (right to buy)
Derivative · Direct		A Grant, award or other acquisition pursuant to Rule 16b-3(d)+95,000
95,000 owned after		$13.00
exercise price		$323.132021-01-07
2021-01-05Lindmark Bertil
Officer (Chief Medical Officer)		4Stock Option (right to buy)
Derivative · Direct		A Grant, award or other acquisition pursuant to Rule 16b-3(d)+95,000
95,000 owned after		$13.00
exercise price		$323.132021-01-07
2020-11-19Dallas Jayson Donald Alexander
Director		4Stock Option (right to buy)
Derivative · Direct		A Grant, award or other acquisition pursuant to Rule 16b-3(d)+18,000
18,000 owned after		$16.60
exercise price		$399.502020-11-23
2020-11-19Dallas Jayson Donald Alexander
Director		4Stock Option (right to buy)
Derivative · Direct		A Grant, award or other acquisition pursuant to Rule 16b-3(d)+9,000
9,000 owned after		$16.60
exercise price		$399.502020-11-23
2020-10-28
holding as of filing		Pedersen Anders
Officer (Chief Operating Officer)		3Stock Option (right to buy)
Derivative · Direct		Holding$4.78
exercise price		2020-10-28
2020-10-28
holding as of filing		Pedersen Anders
Officer (Chief Operating Officer)		3Stock Option (right to buy)
Derivative · Direct		Holding$5.97
exercise price		2020-10-28
2020-10-28
holding as of filing		Pedersen Anders
Officer (Chief Operating Officer)		3Stock Option (right to buy)
Derivative · Direct		Holding$5.97
exercise price		2020-10-28
2020-10-28
holding as of filing		Pedersen Anders
Officer (Chief Operating Officer)		3Stock Option (right to buy)
Derivative · Direct		Holding$1.95
exercise price		2020-10-28
2020-10-28
holding as of filing		Pedersen Anders
Officer (Chief Operating Officer)		3Stock Option (right to buy)
Derivative · Direct		Holding$7.70
exercise price		2020-10-28
2020-10-28
holding as of filing		Lindmark Bertil
Officer (Chief Medical Officer)		3Stock Option (right to buy)
Derivative · Direct		Holding$1.95
exercise price		2020-10-28
2020-10-28
holding as of filing		Freve Jonathan
Officer (Chief Financial Officer)		3Stock Option (right to buy)
Derivative · Direct		Holding$1.95
exercise price		2020-10-28
2020-10-28
holding as of filing		Schambye Hans T.
Director, Officer (Chief Executive Officer)		3Stock Option (right to buy)
Derivative · Direct		Holding$3.98
exercise price		2020-10-28
2020-10-28
holding as of filing		Schambye Hans T.
Director, Officer (Chief Executive Officer)		3Stock Option (right to buy)
Derivative · Direct		Holding$4.78
exercise price		2020-10-28
2020-10-28
holding as of filing		Schambye Hans T.
Director, Officer (Chief Executive Officer)		3Stock Option (right to buy)
Derivative · Direct		Holding$5.97
exercise price		2020-10-28
2020-10-28
holding as of filing		Schambye Hans T.
Director, Officer (Chief Executive Officer)		3Stock Option (right to buy)
Derivative · Direct		Holding$5.97
exercise price		2020-10-28
2020-10-28
holding as of filing		Schambye Hans T.
Director, Officer (Chief Executive Officer)		3Stock Option (right to buy)
Derivative · Direct		Holding$1.95
exercise price		2020-10-28
2020-10-28
holding as of filing		Schambye Hans T.
Director, Officer (Chief Executive Officer)		3Stock Option (right to buy)
Derivative · Direct		Holding$7.70
exercise price		2020-10-28
2020-10-28
holding as of filing		Shapiro David
Director		3Stock Option (right to buy)
Derivative · Direct		Holding$1.95
exercise price		2020-10-28
2020-10-28
holding as of filing		Shapiro David
Director		3Stock Option (right to buy)
Derivative · Direct		Holding$7.70
exercise price		2020-10-28
2020-10-28
holding as of filing		Munshi Amit
Director		3Stock Option (right to buy)
Derivative · Direct		Holding$1.95
exercise price		2020-10-28
2020-10-07Pedersen Anders
Officer (Chief Operating Officer)		4Stock Option (right to buy)
Derivative · Direct		A Grant, award or other acquisition pursuant to Rule 16b-3(d)+77,991
77,991 owned after		$7.70
exercise price		2020-11-04
2020-10-07Schambye Hans T.
Director, Officer (Chief Executive Officer)		4Stock Option (right to buy)
Derivative · Direct		A Grant, award or other acquisition pursuant to Rule 16b-3(d)+519,940
519,940 owned after		$7.70
exercise price		2020-11-04
2020-06-24Pedersen Anders
Officer (Chief Operating Officer)		4Stock Option (right to buy)
Derivative · Direct		A Grant, award or other acquisition pursuant to Rule 16b-3(d)+142,983
142,983 owned after		$1.95
exercise price		2020-11-04
2020-06-24Munshi Amit
Director		4Stock Option (right to buy)
Derivative · Direct		A Grant, award or other acquisition pursuant to Rule 16b-3(d)+109,187
109,187 owned after		$1.95
exercise price		2020-11-04
2020-06-24Schambye Hans T.
Director, Officer (Chief Executive Officer)		4Stock Option (right to buy)
Derivative · Direct		A Grant, award or other acquisition pursuant to Rule 16b-3(d)+207,976
207,976 owned after		$1.95
exercise price		2020-11-04

Similar stocks

Stock NameCountryMarket CapPE Ratio
HARROW, INC. (HROW)United States$1.240B-42.77
Avalyn Pharma Inc. (AVLN)United States$1.267B
OPKO HEALTH, INC. (OPK)United States$1.220B-15.59
LB PHARMACEUTICALS INC (LBRX)United States$1.220B-10.87
First Tracks Biotherapeutics, Inc. (TRAX)United States$1.280B
Bicara Therapeutics Inc. (BCAX)United States$1.309B-10.55
Jaguar Health, Inc. (JAGX)United States$1.184B
Latigo Biotherapeutics, Inc. (LTGO)United States$1.176B
Tyra Biosciences, Inc. (TYRA)United States$1.337B-12.83
Kardigan, Inc. (KARD)United States$1.346B
Advertisement